Finance

Lists
PXMD:OTCMKTS
Kuvatris Therapeutics Inc
0,00070ย $
0,00%
(0,00) 1D
8 ีฐีธีฏ, 14:52:25 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PXMD...
Mkt. cap
88,39ย ีฐีฆึ€
Avg. vol.
163,00
Volume
0,00
52-wk high
0,02ย $
52-wk low
0,00ย $
Shares outstanding
126,26ย ีดีฌีถ
No. of employees
7
Mkt. cap
88,39ย ีฐีฆึ€
Avg. vol.
163,00
Volume
0,00
52-wk high
0,02ย $
52-wk low
0,00ย $
Shares outstanding
126,26ย ีดีฌีถ
No. of employees
7
News stories
From web sources and news partners
Quiver Quantitative
Quiver Quantitative
·
20 ึ€ีธีบีฅ ีกีผีกีป
Hecate Energy Appoints Michael J. Garofola as General Counsel Ahead of Planned Nasdaq Listing
Corsicana Daily Sun
Corsicana Daily Sun
·
28 ึ€ีธีบีฅ ีกีผีกีป
Brightline Interactive Regains Compliance with Nasdaq Minimum Bid Price Requirement
Simply Wall Street
Simply Wall Street
·
3 ึ€ีธีบีฅ ีกีผีกีป
Will New Medicare Plans Change Alignment Healthcare (ALHC) Narrative
AOL.com
AOL.com
·
20 ึ€ีธีบีฅ ีกีผีกีป
The S&P 500 Is Dangerously Concentrated in 5 Tech Giants. Are They Still Buys?
About Kuvatris Therapeutics Inc
CEO-
Employees7
Founded2018
HeadquartersMahwah, ี†ีตีธึ‚ ี‹ีฅึ€ีฝีซ, ี„ีซีกึีตีกีฌ ี†ีกีฐีกีถีฃีถีฅึ€
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2023 ีฉ. ีคีฅีฏ
2024 ีฉ. ีดึ€ีฟ
2024 ีฉ. ีฐีถีฝ
2024 ีฉ. ีฝีฅีบ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
116,93ย ีฐีฆึ€
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
771,00ย ีฐีฆึ€
Operating expense
-
-
-
887,94ย ีฐีฆึ€
Total operating expenses
-
-
-
887,94ย ีฐีฆึ€
Operating income
-
-
-
-887,94ย ีฐีฆึ€
Other non operating income
-
-
-
11,30ย ีฐีฆึ€
EBT including unusual items
-
-
-
-876,64ย ีฐีฆึ€
EBT excluding unusual items
-
-
-
-876,64ย ีฐีฆึ€
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-876,64ย ีฐีฆึ€
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps